1-methyl-delta1-5alpha androstene including esters and process of making the same



United States Patent 3,351,774 1-METHYL-A -a ANDROSTENE INCLUDING ESTERS AND PROCESS OF MAKING THE SAME Josef Hader, Friedmuud Neumann, and Rudolf Wiechert,

Berlin, Germany, assignors to Schering Alrtiengesellschaft, Berlin, German No Drawing. Filed June 14, 1965, Ser. No. 463,852 Claims priority, application Germany, July 22, 1%4, Sch 35,509

4 Claims. (Cl. 266-3914) ABSTRACT OF THE DISCLOSURE 1-methyl-A -5a-androstene-17fi-ol-3-one 17-esters of the general formula /R1 OC-(CH2)nC Rz l R3 CH k J wherein R is chlorine and R and R are members selected from the group consisting of hydrogen and chlorine and wherein n is 0 or 1.

1-methyl-A -5zx-androstene 175-01 3 one is known. Likewise known are the l7-acetate and 17-propionate derivative of this compound. All of these compounds are useful as anabolics.

Surprisingly it was now found that the anabolic effect of the just mentioned compounds can be substantially increased by substituting the alkyl group of the ester residue and particularly of the acetate residue by halogen and preferably chlorine. The thus formed compounds of the invention have been tested in the conventional tests for anabolic and androgenic action using castrated male rats and administering them by subcutaneous application. Surprisingly there resulted not only greater weight increase of the levator ani, but the weight increase of the seminal vesicle was distinctly lower than in the case of the earlier mentioned known compounds. Thus the compounds of the invention provide opportunity for an unusually favorable differentiation of the ratio of activity (Q) between anabolic action and androgenic side effect. This favorable ratio was entirely unpredictable. It is more specifically illustrated by the following table which compares 17-dichloracetate of the invention with the 17-acetate of the prior art:

The compounds of the invention may conveniently be made by esterifying the unsubstituted 17-alcohol with the desired halogenated fatty acid or a reactive derivative Patented Jan. 2, 1968 ice Example 1 1.15 ml. dichloroacetylchloride were added to 3.024 g. of 1-methyl-A -5a-androstene-l7fi-ol-3-one dissolved in 70 ml. pyridine. The addition was made by dropping the acetylchloride into the solution upon stirring and under a nitrogen atmosphere at a temperature of 0 C. The reaction mixture was left overnight at the same temperature of 0. Ice water was then stirred into the mixture followed by acidification with dilute hydrochloric acid and extraction with methylenechloride. The methylenechloride phase was washed out with dilute hydrochloride acid and thereafter with water, was dried over Na SO and concentrated in vacuo by evaporation. The thus obtained crude reaction product was subjected to chromatography with 200 g. SiO +1O+H Cn By elution with a CCl CH Cl mixture and combining of the different fractions one obtained 2.63 g. 1-methyl-A -5mandrostene-17/3-ol-3-one-17-dichloracetate. This product after recrystallization from isopropylether had a melting point between 149 and C.; UV: e =13300.

Example 2 302 mg. of 1-methyl-A -5a-androstene-173-01 3 one were heated together with 3 ml. dichloroacetic acid and 0.8 ml. trifluoraceticacidanhydride in an argon atmosphere for 20 minutes in a steam bath. The reaction mixture was then permitted to cool, ice water was added and extraction effected with methylenechloride. The methylenechloride phase was washed out with a dilute NaHCO solution and then with water and after drying was concentrated in vacuo over Na SO The residue was subjected to recrystallization from isopropylether. There were obtained 250 mg. 1-methyl-A -5u-androstene-175-01-3-or1e- 17-dichloracetate, melting point 148 to 150 C.

Example 3 5 g. of 1-methyl-A -5a-anstrostene-l7,6-ol-3-one were dissolved in 25 ml. pyridine and were reacted dropwise at a temperature between 0 and 5 C. upon stirring during a period of 20 minutes with a solution of 3.11 g. monochloraceticacidanyhdride in 30 ml. abs. ether. Stirring was continued for four hours during which time the temperature of the reaction mixture slowly rose. Excess chloraceticanhydride was decomposed with 1 ml. water. The solution was drop added during one hour to 500 ml. water. The precipitated 1-methyl-A -5a-androstene-17,8- ol-3-one-17-chloracetate was filtered off, then successively washed with 5% HCl, 2% sodium bicarbonate solution and water and was dried in vacuo at 50 C. The yield was 5.9 g. and the melting point 102 to 104 C.; UV: 24 =13380.

Example 4 500 mg. of 1-methyl-A -5a-androstene-17,8-01 3 one were dissolved in 5 ml. triehloracetic acid and 1 ml. triiluoraceticacidanhydride and were subjected to heating for 30 minutes over a steam bath under a nitrogen atmosphere. The mixture was permitted to cool, ice water was added and extraction was effected with methyleneachloride. The methylenechloride phase was washed with dia lute NaHCO solution and water. After drying over Na SO and concentration in vacuo, recrystallization of the cooled product was effected with isopropylether. There were obtained 1-methyl-A Jot-androstene-17,8-01- 3-one-17-trichloracetate melting point 134 to 135 C.; UV: 6 41 13800.

Without further analysis, the foregoing will so fully reveal the gist of the present invention that others can by applying current knowledge readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly constitute essential characteristics of the generic or specific aspects of this invention and, therefore, such adaptations should and are intended to be comprehended within the meaning and range of equivalence of thefollowing claims.

What is claimed as new and desired to be secured by Letters Patent is:

1. An androstene compound consisting of a member selected from the group consisting of UNITED STATES PATENTS 3,236,867 2/1966 Ringold et a1. 260397.4 3,249,628 5/1966 Wiechert 260-397.4 3,258,473 6/1966 Kincl 260-3974 LEWIS GOTTS, Primary Examiner.

I. R. BROWN, Assistant Examiner.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,361,774 January 2, 1968 Josef Hader et a1.

or appears in the above identified It is certified that err Patent are hereby corrected as patent and that said Letters shown below:

Column 3, lines 20 to 31, for that portion of the formula reading 1 1 (f-C-C-R read o-c- -R Signed and sealed this 22nd day of July 1969.

(SEAL) Attest:

WILLIAM E. SCHUYLER, JR.

Edward M. Fletcher, Jr. Attesting Officer Commissioner of Patents 

